{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:40:30Z","timestamp":1777480830528,"version":"3.51.4"},"reference-count":29,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2023,9,5]]},"abstract":"<jats:p>BACKGROUND: Cell surface molecules play important roles in cell signal transduction pathways during microbial infection. OBJECTIVE: In this study, the expression and the functions of CD59 was investigated in H. pylori infected gastric cancer (GC). METHODS AND RESULTS: The differential expression of CD59 and the influence of H. pylori on the expression of CD59 were analyzed via bioinformatics through Gene Set Enrichment in GC. In addition, the expression of CD59 in GES-1, AGS cells and GC tissues infected with H. pylori was confirmed by Western blot. Bioinformatics results and H. pylori infection experiments showed CD59 decreased obviously in H. pylori infected GC cells and tissues. The expression of CD59 was linked to the survival rate of GC patients, and influenced various immune cells in the immune microenvironment of GC. CD59 interacts with other genes to form a network in H. pylori infected GC. Certainly, CD59 decreased significantly in H. pylori infected GC tissues, GES-1 and AGS cells in vitro. CONCLUSION: H. pylori infection could influence the expression of CD59 in GC indicating that CD59 may be a promising treatment target.<\/jats:p>","DOI":"10.3233\/cbm-230034","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T12:24:37Z","timestamp":1690287877000},"page":"27-35","source":"Crossref","is-referenced-by-count":1,"title":["The bioinformatics analysis of CD59 in Helicobacter pylori infected gastric cancer"],"prefix":"10.1177","volume":"38","author":[{"given":"Jun","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Medical Service, Kunshan First People\u2019s Hospital, Kunshan, Jiangsu, China"},{"name":"Department of Medical Service, Kunshan First People\u2019s Hospital, Kunshan, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of food safety and evaluation, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China"},{"name":"Department of Medical Service, Kunshan First People\u2019s Hospital, Kunshan, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kunshan First People\u2019s Hospital, Kunshan, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kunshan First People\u2019s Hospital, Kunshan, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kunshan First People\u2019s Hospital, Kunshan, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kunshan First People\u2019s Hospital, Kunshan, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, the Affiliated Changzhou No. 2 People\u2019s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-230034_ref1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"10.3233\/CBM-230034_ref2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.3233\/CBM-230034_ref3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbcan.2017.11.003","article-title":"Genetic host factors in Helicobacter pylori-induced carcinogenesis: Emerging new paradigms","volume":"1869","author":"Mommersteeg","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.3233\/CBM-230034_ref4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jcmgh.2016.12.001","article-title":"The clinical evidence linking Helicobacter pylori to gastric cancer","volume":"3","author":"Moss","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.3233\/CBM-230034_ref5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Science"},{"key":"10.3233\/CBM-230034_ref6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.33899\/mmed.2020.164156","article-title":"Helicobacter pylori in gastric biopsy: A histochemical and immunohistochemical assessment","volume":"41","author":"Aziz","year":"2019","journal-title":"Ann Coll Med Mosul"},{"key":"10.3233\/CBM-230034_ref7","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1056\/NEJMcp1710945","article-title":"Helicobacter pylori infection","volume":"380","author":"Crowe","year":"2019","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-230034_ref8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mib.2006.12.004","article-title":"The role of bacterial pathogens in cancer","volume":"10","author":"Vogelmann","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"10.3233\/CBM-230034_ref9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/path.1868","article-title":"Helicobacter infection and gastric neoplasia","volume":"208","author":"Peek","year":"2006","journal-title":"J Pathol"},{"key":"10.3233\/CBM-230034_ref10","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.3892\/or.2016.5145","article-title":"Pathogenic mechanisms of the oncoprotein CagA inH. pylori-induced gastric cancer (Review)","volume":"36","author":"Chen","year":"2016","journal-title":"Oncol Rep"},{"key":"10.3233\/CBM-230034_ref11","doi-asserted-by":"crossref","first-page":"102836","DOI":"10.1016\/j.dnarep.2020.102836","article-title":"Helicobacter pylori severely reduces expression of DNA repair proteins PMS2 and ERCC1 in gastritis and gastric cancer","volume":"89","author":"Raza","year":"2020","journal-title":"DNA Repair"},{"key":"10.3233\/CBM-230034_ref12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-230034_ref13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1242\/dmm.027649","article-title":"Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models","volume":"10","author":"Burkitt","year":"2017","journal-title":"Dis Model Mech"},{"key":"10.3233\/CBM-230034_ref14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/5584_2019_363","article-title":"Malignant Helicobacter pylori-associated diseases: gastric cancer and MALT lymphoma","volume":"1149","author":"Hatakeyama","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/CBM-230034_ref15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000521174","article-title":"Association of blood group antigen CD59 with disease","volume":"49","author":"Weinstock","year":"2022","journal-title":"Transfus Med Hemother"},{"key":"10.3233\/CBM-230034_ref16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.5858\/arpa.2013-0064-OA","article-title":"Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer","volume":"138","author":"Shang","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.3233\/CBM-230034_ref17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/gast.2001.21197","article-title":"Survival of Helicobacter pylori From complement lysis by binding of GPI-anchored protectin (CD59)","volume":"120","author":"Rautemaa","year":"2001","journal-title":"Gastroenterology"},{"key":"10.3233\/CBM-230034_ref18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1365-2249.2000.01305.x","article-title":"Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack","volume":"121","author":"Spiller","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.3233\/CBM-230034_ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-1302-3_1","article-title":"An Overview of Helicobacter pylori Infection","volume":"2283","author":"FitzGerald","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.3233\/CBM-230034_ref20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.170.3.637","article-title":"CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells","volume":"170","author":"Davies","year":"1989","journal-title":"J Exp Med"},{"key":"10.3233\/CBM-230034_ref21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2217\/fon-2017-0498","article-title":"CD59: A promising target for tumor immunotherapy","volume":"14","author":"Zhang","year":"2018","journal-title":"Future Oncol"},{"key":"10.3233\/CBM-230034_ref22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2217\/fon-2017-0498","article-title":"CD59: A promising target for tumor immunotherapy","volume":"14","author":"Zhang","year":"2018","journal-title":"Future Oncol"},{"key":"10.3233\/CBM-230034_ref23","doi-asserted-by":"crossref","first-page":"e85934","DOI":"10.1371\/journal.pone.0085934","article-title":"Lck mediates signal transmission from CD59 to the TCR\/CD3 pathway in Jurkat T cells","volume":"9","author":"Lipp","year":"2014","journal-title":"PLoS ONE"},{"key":"10.3233\/CBM-230034_ref24","first-page":"8304","article-title":"Function and subsets of dendritic cells and natural killer cells were decreased in gastric cancer","volume":"7","author":"Chen","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.3233\/CBM-230034_ref25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1054\/mehy.2001.1476","article-title":"P53 possibly upregulates the expression of CD58 (LFA-3) and CD59 (MIRL)","volume":"58","author":"Sampaziotis","year":"2002","journal-title":"Med Hypotheses"},{"key":"10.3233\/CBM-230034_ref26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1537-2995.2008.01936.x","article-title":"Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein-\u03b1, \u03b2 on monocytes from patients with warm autoimmune hemolytic anemia","volume":"49","author":"Barros","year":"2009","journal-title":"Transfusion (Paris)"},{"key":"10.3233\/CBM-230034_ref27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molimm.2015.03.005","article-title":"Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities","volume":"67","author":"Mevorach","year":"2015","journal-title":"Mol Immunol"},{"key":"10.3233\/CBM-230034_ref28","doi-asserted-by":"crossref","first-page":"26274","DOI":"10.1038\/srep26274","article-title":"Soluble CD59 is a novel biomarker for the prediction of obstructive chronic lung allograft dysfunction after lung transplantation","volume":"6","author":"Budding","year":"2016","journal-title":"Sci. Rep"},{"key":"10.3233\/CBM-230034_ref29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/er.2014-1099","article-title":"Role of complement and complement regulatory proteins in the complications of diabetes","volume":"36","author":"Ghosh","year":"2015","journal-title":"Endocr Rev"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-230034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:10:17Z","timestamp":1777385417000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-230034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":29,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/cbm-230034","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,5]]}}}